Executive Director’s Message – April 2025
At the UF Health Proton Therapy Institute, we are deeply grateful for the dedication and expertise of our physicians, research staff and nurses who are moving cancer treatment forward each day. Their commitment to innovation and compassionate patient care is unwavering.
Letter to the Editor
The gratitude I have for each member of that research team as well as to every doctor and technician administering the program is so great.
Brain Cancer
Boy from Australia Completes Proton Therapy for Brain Tumor
A community of friends, family, neighbors and fellow Australians he had never met rallied around a young boy from a small seaside town last December.
Dr. Jean-Baptiste Shares Clinical Research
In October 2024, Samuel Jean-Baptiste, MD, MS, joined the UF Health Proton Therapy Institute. Dr. Jean-Baptiste is actively treating patients for brain, lung and prostate cancers.
Help Others Find Proton Therapy
On March 30, we honored Doctors' Day, and in May National Nurses Month is celebrated to honor nurses and their contributions to healthcare.
Doctors’ Day: Compassionate Care in Treating Choroidal Melanoma
When Michael Klein received his cancer diagnosis, choroidal melanoma of the left eye, it was a frightening time. "It was one of the most terrifying moments that I have ever had," Michael said.
Students Welcomed at the UF Health Proton Therapy Institute
In March, 40 Duval County students and parents from First Coast High School and the AnnieRuth Foundation visited the UF Health Proton Therapy Institute to learn from our staff what kind of careers are available in healthcare, specifically related to radiation for cancer treatment.
The UF Health Proton Therapy Institute Launches its Forward Campaign
In February, the UF Health Proton Therapy Institute launched a new advertising campaign, “Forward For You.” The campaign shines a light on what sets the Institute apart—our commitment to advances in cancer treatment with proton therapy and our commitment to our patients.
Clinical Research Professionals Work to Advance Cancer Care Through Clinical Trials
The Clinical Research Department at the UF Health Proton Therapy Institute is a diverse group of specialists who work behind the scenes supporting the physicians in their goal to improve patient care and treatment outcomes.
Blog Spot: What is Oropharyngeal Cancer?
Oropharyngeal cancer, the most common head and neck cancer in the United States, is a malignant tumor of the tonsil, soft palate and/or base of tongue.
Proton Therapy News Brief Roundup
Catch up on the news and developments at the UF Health Proton Therapy Institute.
- Open access to research
- A new study examines patient education and anxiety
Community Calendar
Mark your calendar and join us when we are in a town near you or online.
For patient events at the UF Health Proton Therapy Institute, go to For Patients & Families for details.
Active After 50 Expo
Location: Thrasher-Horne Conference Center, 283 College Dr., Orange Park, FL 32065
UF Health Proton Therapy Institute will be at this year’s Active After 50 Expo in Orange Park with information and giveaways! The Active After 50 Expos provide a fun event to promote active lifestyles for Baby Boomers & Seniors. Come out for this FREE community event! Find out more at https://activeafter50online.com/.
For More Info: Contact Christina at 904.831.4034 or education@floridaproton.org
Want to keep up-to-date? Enter your email below to be added to our monthly email list.
About This Newsletter
The Precision Newsletter is an electronic-only publication that is distributed by email. Each issue is sent periodically to patients, alumni patients and friends of the University of Florida Health Proton Therapy Institute. As the official newsletter of the Institute, the content is compiled and prepared by our communications
representative and approved by the editor. Special bulletin newsletters may occasionally be prepared when timely topics and new developments in proton therapy occur. If you would like to send a Letter to the Editor, please click here.